By Eddie Beaver ( November 24, 2025, 5:13 PM GMT) -- A pharmaceuticals company has asked a court to revoke Janssen's two patents that cover how an injectable form of schizophrenia medication should be given to patients who miss a dose, arguing that the regimens were obvious when they were registered....

See Full Page